Endometrium cancer diagnose reagent, reagent kit and controlling medicament
An endometrial cancer and drug technology, applied in the field of tumor molecular biology, can solve the problems of no diagnostic reagents and kits for diagnosing endometrial cancer, no prevention and treatment of endometrial cancer, etc. Survival rate, the effect of broad application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] Example 1 Preliminary determination of human cyclophilin A protein as a protein related to the occurrence and development of endometrial cancer
[0042] 1. Sources of endometrioid adenocarcinoma and normal endometrial tissue specimens in proliferative phase
[0043]The endometrial cancer tissue specimens used in this example were collected from endometrial cancer patients undergoing surgical treatment in the Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University, from March to May 2006. The age distribution of the patients was between 45 and 60 years old, with an average age of 52.75±4.71 years old. All patients received no chemotherapy or radiotherapy before operation, and the postoperative pathological diagnosis was clear with complete clinical data. Normal endometrial specimens were collected from patients with benign diseases such as uterine fibroids who underwent surgical treatment in the Obstetrics and Gynecology Department of the...
Embodiment 2
[0064] Example 2 Verification that human cyclophilin A protein is a protein related to the occurrence and development of endometrial cancer
[0065] RT-PCR and Western Blot were used to verify the expression difference of human cyclophilin A between endometrial carcinoma and normal endometrium at mRNA and protein levels.
[0066] 1. Reagent source
[0067] RT-PCR related reagents: Trizol Reagent was purchased from Invitrogen; Oligo(dT), MgCl 2 , dNTPmix, RNase Inhibitor, AMV-Optimized Taq, AMV RTase XL, etc. were purchased from TaKaRa Company.
[0068] Western Blot related reagents: rabbit anti-human human cyclophilin A polyclonal antibody was purchased from Upstate; mouse anti-human β-actin monoclonal antibody was purchased from Santa Cruz; horseradish peroxidase (HRP)-labeled goat anti-rabbit IgG and goat anti-mouse IgG (secondary antibody) were purchased from Beijing Zhongshan Jinqiao Biotechnology Co., Ltd.; protein pre-stained Marker was purchased from MBI Company; nitr...
Embodiment 3
[0109] Example 3. Immunohistochemical Analysis of the Expression of Human Cyclophilin A in Endometrial Carcinoma and Normal Endometrium Tissue
[0110] 1. Source of tissue samples
[0111] Paraffin specimens were obtained from the Department of Pathology, West China Second Hospital, Sichuan University. Among them, endometrial cancer specimens were collected from 52 patients with endometrial cancer who underwent surgery in the Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University, from March 2005 to March 2006. The pathological diagnosis was all endometrioid adenocarcinoma, including 20 cases of well-differentiated adenocarcinoma, 20 cases of moderately differentiated adenocarcinoma, and 12 cases of poorly differentiated adenocarcinoma; surgical pathological staging was stage I in 40 cases, stage II in 8 cases, and stage III in 4 cases. example. Normal endometrial samples were collected from 39 patients with benign diseases such as uterine fi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com